Myocardial protection of insulin and potassium in a porcine ischemia-reperfusion model
- PMID: 19541007
- DOI: 10.1016/j.surg.2009.03.028
Myocardial protection of insulin and potassium in a porcine ischemia-reperfusion model
Abstract
Background: We previously evaluated cardioprotective effects of glucose-insulin-potassium (GIK) in a porcine ischemia-reperfusion model; our results showed less myocardial pH decrease during ischemia and reperfusion and faster normalization of ATP and glucose during reperfusion. The proposed protective mechanism was facilitation of glucose transport for myocardial metabolism. The objective of this study was to assess the impact of insulin-potassium (IK) alone on myocardial metabolism.
Methods: Male swine received continuous infusion of IK (IK group, n = 10), GIK (GIK group, n = 10), or standard lactated Ringer's (LR) solution (controls, n = 10). Induction of 20 minutes of ischemia in the left anterior descending (LAD) artery distribution was followed by 20 minutes of reperfusion. Real-time biosensors recorded pH and glucose levels in ischemic and nonischemic beds. Myocardial biopsies in the distribution of the LAD assessed ATP levels. Groups were compared using the Kruskal-Wallis and Mann-Whitney tests.
Results: Real-time data are presented as percent change from baseline. At less than 10 minutes of ischemia, the average pH change was less for the IK group than the LR group (0.03% +/- 0.21% vs -2.06% +/- 1.23%; P = .001), and the pH change in the IK group was similar to the GIK group. After 10 minutes of ischemia and during the first 10 minutes of reperfusion, the IK group experienced pH changes that were similar to the LR group. Biopsies after 20 minutes of ischemia and 20 minutes of reperfusion showed less of a decline in ATP levels for the IK group compared to the LR group. Glucose at all time points demonstrated no statistically significant differences.
Conclusion: IK infusion alone demonstrates cardioprotective effects during early ischemia; however, compared to GIK infusion after 20 minutes of ischemia and reperfusion, myocardial pH and glucose levels were not sustained. Although insulin may facilitate glucose transport during ischemia, additional glucose in combination with IK enhances myocardial protection during reperfusion. This finding suggests that GIK enhancement during acute ischemia-reperfusion may improve myocardial protection.
Similar articles
-
Real-time monitoring of cardiac metabolism using biosensors shows myocardial protection during ischemia-reperfusion injury with glucose-insulin-potassium administration.Surgery. 2007 Aug;142(2):150-5. doi: 10.1016/j.surg.2007.03.005. Surgery. 2007. PMID: 17689679
-
Physiologically tolerable insulin reduces myocardial injury and improves cardiac functional recovery in myocardial ischemic/reperfused dogs.J Cardiovasc Pharmacol. 2006 Dec;48(6):306-13. doi: 10.1097/01.fjc.0000249873.73197.c3. J Cardiovasc Pharmacol. 2006. PMID: 17204910
-
Acute hyperglycemia exacerbates myocardial ischemia/reperfusion injury and blunts cardioprotective effect of GIK.Am J Physiol Endocrinol Metab. 2007 Sep;293(3):E629-35. doi: 10.1152/ajpendo.00221.2007. Epub 2007 May 22. Am J Physiol Endocrinol Metab. 2007. PMID: 17519283
-
Effects of glucose-insulin-potassium (GIK) on myocardial blood flow and metabolism in canine endotoxin shock.Circ Shock. 1984;13(4):325-40. Circ Shock. 1984. PMID: 6383652 Review.
-
Insulin therapy as an adjunct to reperfusion after acute coronary ischemia: a proposed direct myocardial cell survival effect independent of metabolic modulation.J Am Coll Cardiol. 2003 Apr 16;41(8):1404-7. doi: 10.1016/s0735-1097(03)00164-5. J Am Coll Cardiol. 2003. PMID: 12706939 Review.
Cited by
-
Treating diabetes with combination of phosphodiesterase 5 inhibitors and hydroxychloroquine-a possible prevention strategy for COVID-19?Mol Cell Biochem. 2023 Mar;478(3):679-696. doi: 10.1007/s11010-022-04520-2. Epub 2022 Aug 29. Mol Cell Biochem. 2023. PMID: 36036333 Free PMC article. Review.
-
PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice.J Pharmacol Exp Ther. 2017 Apr;361(1):29-38. doi: 10.1124/jpet.116.239087. Epub 2017 Jan 25. J Pharmacol Exp Ther. 2017. PMID: 28123046 Free PMC article.
-
Hemodynamic Effects of Cardiovascular Medications in a Normovolemic and Hemorrhaged Yorkshire-cross Swine Model.Comp Med. 2022 Feb 1;72(1):38-44. doi: 10.30802/AALAS-CM-21-000080. Epub 2021 Dec 7. Comp Med. 2022. PMID: 34876241 Free PMC article.
-
Cardiometabolism as an Interlocking Puzzle between the Healthy and Diseased Heart: New Frontiers in Therapeutic Applications.J Clin Med. 2021 Feb 12;10(4):721. doi: 10.3390/jcm10040721. J Clin Med. 2021. PMID: 33673114 Free PMC article. Review.
-
Glucose-insulin-potassium therapy in patients with acute coronary syndrome: a meta-analysis of randomized controlled trials.BMC Cardiovasc Disord. 2014 Nov 25;14:169. doi: 10.1186/1471-2261-14-169. BMC Cardiovasc Disord. 2014. PMID: 25425404 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical